Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

19

Number of overlapping holdings

47.5%

% of HRTS's 40 holdings also in XLV

31.1%

% of XLV's 61 holdings also in HRTS

Overlap by Weight
Sector Drift (HRTS minus XLV)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in HRTS
Weight
in XLV
Overlap
ELI LILLY & CO 9.8% 12.6% 9.8%
UNITEDHEALTH GROUP INC 5.9% 9.1% 5.9%
ABBOTT LABORATORIES 3.7% 4.3% 3.7%
MERCK & CO. INC. 3.1% 4.0% 3.1%
BOSTON SCIENTIFIC CORP 3.1% 3.0% 3.0%

Position Highlights (Non-Overlapping Exposures)
HRTS Overweight Relative to XLV
BRIDGEBIO PHARMA, INC. 4.3%
ASTRAZENECA PLC 4.1%
ROCHE HOLDINGS LTD-SPONS ADR 3.7%
NOVO NORDISK A/S-B 3.7%
CHUGAI PHARMACEUTICAL CO LTD 3.3%
NOVARTIS AG 2.7%
CRINETICS PHARMACEUTICALS INC 2.1%
MASIMO CORPORATION 2.0%
CYTOKINETICS INC 1.9%
ALNYLAM PHARMACEUTICALS INC 1.9%
HRTS Underweight Relative to XLV
JOHNSON & JOHNSON -7.1%
ABBVIE INC -4.0%
INTUITIVE SURGICAL INC -4.0%
UNITEDHEALTH GROUP INC -3.2%
ELI LILLY & CO -2.8%
PFIZER INC -2.7%
STRYKER CORP -2.5%
ELEVANCE HEALTH INC -1.7%
CVS CAREMARK CORP -1.6%
CIGNA CORPORATION -1.5%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY